| abstract |
Methods and compositions are disclosed utilizing the optically pure (-)-isomer of bupropion, which is a potent drug for treating depression, Parkinson's disease, obesity, weight gain, bipolar disorders, attention-deficit disorders, conduct disorders, phycho-sexual dysfunction, bulimia, eating disorders or specific food craving. The composition can be administered intravenously, transdermally (patch) or orally, possibily in a sustained release form. |